Melphalan (Melpha) Inj 50 mg vial: Hospital supply issue

Supply issue Hospital only Active

Luminarie, the incoming supplier of melphalan inj 50 mg vial (Melpha brand, Pharmacode 2647699), has notified of ongoing issues in sourcing stock.

14 June 2024 Update

A new shipment of Megval (Pharmacode 2676842) has arrived in Aotearoa and is available to be ordered from Healthcare Logistics (HCL)

Affected product

In December 2023, Luminarie's Melpha brand gained principal supply status. There have been on-going supply issues affecting the supply of this product.

  • Chemical: Melphalan
  • Presentation: Inj 50 mg vial
  • Brand: Melpha
  • Pharmacode: 2647699
  • Price: $48.25
  • Measure / Qty: per 1

Alternatives

To cover this supply issue both the previously funded brand (Alkeran) and an alternative brand, Megval (Pharmacode 2676842) have been provided. 

A new shipment of Megval has arrived in Aotearoa and is available to be ordered from Healthcare Logistics (HCL).

Expected resupply

Resupply of the registered brand (Melpha) has been delayed with no firm delivery date.

Who to contact

If you have questions about this issue, email enquiry@pharmac.govt.nz

Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.

Sign up to our email list for regular emails about supply issues and more(external link)